Konstantin Adamsky

Director/Miembro de la Junta en FILAMENT HEALTH CORP. .

53 años

Health Technology

Consumer Services

Cargos activos de Konstantin Adamsky

Empresas	Cargo	Inicio	Fin
FILAMENT HEALTH CORP.	Director/Miembro de la Junta	23/08/2022	-
FILAMENT HEALTH CORP.	Independent Dir/Board Member	23/08/2022	-

Empresas	Cargo	Inicio	Fin
Regenera Pharma Ltd. Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel.	Director Ejecutivo	-	01/08/2017
	Director de Operaciones	01/08/2017	01/10/2020
Levco Pharmaceuticals Ltd.	Director de Operaciones	-	-

Weizmann Institute of Science

Doctorate Degree

Internacional

Israel	4
Canadá	2

Operativa

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
FILAMENT HEALTH CORP.	Health Technology

Empresas privadas	2
Regenera Pharma Ltd. Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel.	Health Technology
Levco Pharmaceuticals Ltd.

Empresas privadas

Health Technology

Levco Pharmaceuticals Ltd.